InnoCare Pharma Limited (OTCMKTS:INCPF) Sees Significant Decline in Short Interest

InnoCare Pharma Limited (OTCMKTS:INCPF) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 1,710,000 shares, a drop of 43.9% from the February 28th total of 3,046,000 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

InnoCare Pharma Price Performance

Shares of OTCMKTS INCPF remained flat at $3.26 during midday trading on Friday. InnoCare Pharma has a 52-week low of $3.26 and a 52-week high of $3.72. The firm has a 50-day moving average price of $3.26 and a two-hundred day moving average price of $3.26.

About InnoCare Pharma

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.